tiprankstipranks
Daito Pharmaceutical Co., Ltd. (JP:4577)
:4577
Japanese Market
4577
Daito Pharmaceutical Co., Ltd.
RESEARCH TOOLSreports
Want to see JP:4577 full AI Analyst Report?

Daito Pharmaceutical Co., Ltd. (4577) Ratios

0 Followers

Daito Pharmaceutical Co., Ltd. Ratios

JP:4577's free cash flow for Q1 2025 was ¥0.20. For the 2025 fiscal year, JP:4577's free cash flow was decreased by ¥ and operating cash flow was ¥0.08. See a summary of the company’s cash flow.
Ratios
TTM
May 24May 23May 22May 21
Liquidity Ratios
Current Ratio
 2.50 2.45 2.24 2.64 2.69
Quick Ratio
 1.30 1.37 1.11 1.45 1.50
Cash Ratio
 0.12 0.13 0.15 0.23 0.31
Solvency Ratio
 0.27 0.24 0.27 0.38 0.46
Operating Cash Flow Ratio
 0.06 0.35 0.28 0.27 0.31
Short-Term Operating Cash Flow Coverage
 0.27 1.90 2.47 2.77 3.64
Net Current Asset Value
¥ 15.69B¥ 15.78B¥ 16.02B¥ 21.08B¥ 20.64B
Leverage Ratios
Debt-to-Assets Ratio
 0.14 0.15 0.11 0.07 0.05
Debt-to-Equity Ratio
 0.19 0.23 0.17 0.10 0.07
Debt-to-Capital Ratio
 0.16 0.19 0.14 0.09 0.07
Long-Term Debt-to-Capital Ratio
 0.08 0.11 0.08 0.06 0.05
Financial Leverage Ratio
 1.43 1.50 1.49 1.39 1.37
Debt Service Coverage Ratio
 1.67 1.79 3.21 4.91 6.44
Interest Coverage Ratio
 26.16 21.31 94.98 433.92 728.11
Debt to Market Cap
 0.22 0.32 0.39 0.29 0.19
Interest Debt Per Share
 350.10 394.73 558.28 314.26 225.74
Net Debt to EBITDA
 1.22 1.39 0.76 0.15 -0.09
Profitability Margins
Gross Profit Margin
18.47%16.73%20.98%22.91%26.36%
EBIT Margin
6.90%5.18%9.08%11.28%15.11%
EBITDA Margin
13.31%13.73%16.89%19.86%22.73%
Operating Profit Margin
6.90%5.18%8.30%11.55%15.08%
Pretax Profit Margin
7.52%5.84%8.99%11.25%15.46%
Net Profit Margin
5.83%3.77%7.03%7.98%10.74%
Continuous Operations Profit Margin
5.80%3.49%6.78%7.82%10.65%
Net Income Per EBT
77.50%64.50%78.12%70.92%69.46%
EBT Per EBIT
108.93%112.86%108.32%97.48%102.55%
Return on Assets (ROA)
3.95%2.45%4.24%5.10%7.19%
Return on Equity (ROE)
5.67%3.67%6.33%7.10%9.87%
Return on Capital Employed (ROCE)
5.88%4.30%6.58%9.45%12.88%
Return on Invested Capital (ROIC)
4.29%2.43%4.76%6.39%8.67%
Return on Tangible Assets
4.01%2.46%4.27%5.13%7.23%
Earnings Yield
8.15%6.37%18.87%21.75%25.63%
Efficiency Ratios
Receivables Turnover
 2.92 2.50 3.04 2.55 2.69
Payables Turnover
 4.34 5.10 4.26 7.84 7.12
Inventory Turnover
 2.26 2.29 1.77 1.91 1.90
Fixed Asset Turnover
 1.61 1.59 1.47 1.75 1.88
Asset Turnover
 0.68 0.65 0.60 0.64 0.67
Working Capital Turnover Ratio
 2.21 2.13 1.95 1.84 2.00
Cash Conversion Cycle
 202.51 233.80 240.26 287.77 276.17
Days of Sales Outstanding
 125.20 145.98 120.18 142.87 135.59
Days of Inventory Outstanding
 161.37 159.37 205.77 191.45 191.82
Days of Payables Outstanding
 84.06 71.55 85.68 46.56 51.24
Operating Cycle
 286.58 305.34 325.95 334.33 327.41
Cash Flow Ratios
Operating Cash Flow Per Share
 31.32 193.85 330.25 262.73 285.44
Free Cash Flow Per Share
 -51.88 -31.46 -69.72 -88.59 -23.71
CapEx Per Share
 83.20 225.30 399.97 351.32 309.15
Free Cash Flow to Operating Cash Flow
 -1.66 -0.16 -0.21 -0.34 -0.08
Dividend Paid and CapEx Coverage Ratio
 0.34 0.75 0.72 0.64 0.81
Capital Expenditure Coverage Ratio
 0.38 0.86 0.83 0.75 0.92
Operating Cash Flow Coverage Ratio
 0.09 0.50 0.59 0.84 1.27
Operating Cash Flow to Sales Ratio
 0.02 0.12 0.11 0.09 0.10
Free Cash Flow Yield
-4.23%-3.19%-6.26%-8.46%-1.99%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 12.31 15.70 5.30 4.60 3.90
Price-to-Sales (P/S) Ratio
 0.71 0.59 0.37 0.37 0.42
Price-to-Book (P/B) Ratio
 0.70 0.58 0.34 0.33 0.38
Price-to-Free Cash Flow (P/FCF) Ratio
 -23.73 -31.31 -15.96 -11.82 -50.17
Price-to-Operating Cash Flow Ratio
 39.59 5.08 3.37 3.98 4.17
Price-to-Earnings Growth (PEG) Ratio
 0.30 -0.39 -0.68 -0.18 0.50
Price-to-Fair Value
 0.70 0.58 0.34 0.33 0.38
Enterprise Value Multiple
 6.58 5.70 2.96 2.00 1.75
Enterprise Value
 44.33B 39.64B 23.46B 17.91B 17.28B
EV to EBITDA
 6.56 5.70 2.96 2.00 1.75
EV to Sales
 0.87 0.78 0.50 0.40 0.40
EV to Free Cash Flow
 -29.08 -41.42 -21.44 -12.78 -47.60
EV to Operating Cash Flow
 48.18 6.72 4.53 4.31 3.95
Tangible Book Value Per Share
 1.74K 1.69K 3.30K 3.20K 3.09K
Shareholders’ Equity Per Share
 1.78K 1.71K 3.32K 3.20K 3.09K
Tax and Other Ratios
Effective Tax Rate
 0.23 0.40 0.25 0.31 0.31
Revenue Per Share
 1.73K 1.66K 2.99K 2.85K 2.84K
Net Income Per Share
 100.73 62.72 209.99 227.64 304.90
Tax Burden
 0.78 0.65 0.78 0.71 0.69
Interest Burden
 1.09 1.13 0.99 1.00 1.02
Research & Development to Revenue
 0.00 0.05 0.05 0.04 0.04
SG&A to Revenue
 0.12 0.07 0.00 0.00 0.00
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 0.46 3.09 1.23 0.82 0.65
Currency in JPY